HUP0004647A3 - Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye - Google Patents

Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Info

Publication number
HUP0004647A3
HUP0004647A3 HU0004647A HUP0004647A HUP0004647A3 HU P0004647 A3 HUP0004647 A3 HU P0004647A3 HU 0004647 A HU0004647 A HU 0004647A HU P0004647 A HUP0004647 A HU P0004647A HU P0004647 A3 HUP0004647 A3 HU P0004647A3
Authority
HU
Hungary
Prior art keywords
glycosaminoglycans
eye
pharmaceutical preparations
treating diabetes
associated diseases
Prior art date
Application number
HU0004647A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of HUP0004647A2 publication Critical patent/HUP0004647A2/hu
Publication of HUP0004647A3 publication Critical patent/HUP0004647A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HU0004647A 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye HUP0004647A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747195A DE19747195A1 (de) 1997-10-24 1997-10-24 Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
PCT/EP1998/006703 WO1999021538A2 (de) 1997-10-24 1998-10-22 Verwendung von glykosaminoglykanen zur herstellung von pharmazeutischen zubereitungen zur behandlung von mit diabetes assoziierten augenkrankheiten

Publications (2)

Publication Number Publication Date
HUP0004647A2 HUP0004647A2 (hu) 2001-05-28
HUP0004647A3 true HUP0004647A3 (en) 2002-01-28

Family

ID=7846613

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004647A HUP0004647A3 (en) 1997-10-24 1998-10-22 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye

Country Status (13)

Country Link
EP (1) EP1047434A2 (ko)
JP (1) JP2001520987A (ko)
KR (1) KR20010024550A (ko)
CN (1) CN1277554A (ko)
AU (1) AU749673B2 (ko)
BR (1) BR9813098A (ko)
CA (1) CA2306379A1 (ko)
DE (1) DE19747195A1 (ko)
HU (1) HUP0004647A3 (ko)
IL (1) IL135171A0 (ko)
NO (1) NO20001895L (ko)
WO (1) WO1999021538A2 (ko)
ZA (1) ZA989665B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
CN101584704B (zh) * 2008-05-23 2010-12-15 鲁南制药集团股份有限公司 肝素、低分子肝素可药用盐或其衍生物的医药用途
WO2011122321A1 (ja) * 2010-03-29 2011-10-06 国立大学法人名古屋大学 ヘパリン結合性蛋白に対する生理活性阻害剤
CN107137421A (zh) * 2017-05-25 2017-09-08 青岛市中心医院 硫酸葡聚糖在制备抑制角膜血管新生药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
DE3875349D1 (de) * 1988-06-27 1992-11-19 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
WO1995005182A1 (en) * 1993-08-13 1995-02-23 Glycomed Incorporated Bridged oligosaccharides and sulfated derivatives thereof
EP0722326A4 (en) * 1993-10-07 1999-10-06 Glycomed Inc HIGHLY SULFATED MALTOOLIGOSSACCHARIDES WITH HEPARIN-LIKE PROPERTIES
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
WO1999004801A1 (en) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy

Also Published As

Publication number Publication date
NO20001895D0 (no) 2000-04-12
NO20001895L (no) 2000-04-12
DE19747195A1 (de) 1999-04-29
AU749673B2 (en) 2002-07-04
EP1047434A2 (de) 2000-11-02
CN1277554A (zh) 2000-12-20
IL135171A0 (en) 2001-05-20
KR20010024550A (ko) 2001-03-26
ZA989665B (en) 2000-04-25
JP2001520987A (ja) 2001-11-06
CA2306379A1 (en) 1999-05-06
BR9813098A (pt) 2000-08-15
HUP0004647A2 (hu) 2001-05-28
WO1999021538A3 (de) 1999-08-05
AU1335599A (en) 1999-05-17
WO1999021538A2 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU2639695A (en) Novel uses of triplex forming oligonucleotides for the treatment of human diseases
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
AU4048295A (en) Peptide medicaments for the treatment of disease
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
ZA983602B (en) Use of tetrahydropyridine derivatives for the preparation of drugs for the treatment of diseases which cause demyelination
EP1010435A4 (en) PREPARATIONS OF NANOCAPSULES FOR THE TREATMENT OF INTRA-ARTICULAR DISEASES
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
AU9173191A (en) Medicaments for the treatment of papillomavirus diseases
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
PL336760A1 (en) Treatment of skin diseases
EP0791358A4 (en) REMEDY FOR OPHTHALMIC DISORDERS
AU3684395A (en) Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
EP0790062A4 (en) REMEDY FOR HEART DISEASE
IL135171A0 (en) Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
HK1016180A1 (en) Process for the preparation of anti-malarial drugs
AU8185491A (en) Treatment of disease
AU7449698A (en) Therapeutic agents for respiratory diseases
IL120005A (en) Pharmaceutical compositions for the treatment of the eye
EP0878200A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
AU3190595A (en) Corneal therapeutic agent
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
ZA987960B (en) Methods for treating ocular diseases